Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AACR news: Javelin-based vaccine safe and immunogenic in melanoma patients

April 16, 2002

Squalamine effective in breast cancer model alone and in combination with Herceptin

April 16, 2002

Hedgehog antagonist with potential in BCC identified at Curis using novel screening assays

April 16, 2002

Agouron designs new series with protein kinase-inhibitory and antitumor activity

April 15, 2002

Inhibitors of Src tyrosine kinases reported by AstraZeneca

April 15, 2002

ChemGenex uses chemical genomics to advance experimental anticancer drugs

April 15, 2002

Health Canada approves phase I/II Reolysin trial in patients with recurrent malignant glioma

April 15, 2002

Preliminary phase I results for ILX-651 discussed at AACR meeting

April 15, 2002

Preclinical characterization of Ro-31-7453, a new cell cycle inhibitor

April 15, 2002

Potent inhibitors of angiogenesis derived from thrombospondin-1

April 15, 2002

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...